Molecular Cancer Research Targeting the PI3-Kinase Pathway in Cancer Chemical and Biological Aspects of Inflammation and Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Crosetto, N.
Right arrow Articles by Dikic, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Crosetto, N.
Right arrow Articles by Dikic, I.
Related Collections
Right arrow Cellular Pathobiology
Right arrow Cellular Pathobiology: Metabolism and Physiology
Molecular Cancer Research 4:899-904 (2006)
© 2006 American Association for Cancer Research


Subject Review

Ubiquitin Hubs in Oncogenic Networks

Nicola Crosetto, Marzena Bienko and Ivan Dikic

Institute of Biochemistry II, Goethe University Hospital, Frankfort on the Main, Germany

Requests for reprints: Ivan Dikic, Institute of Biochemistry II, Goethe University Hospital, Theodor-Stern-Kai 7, D-60590 Frankfort on the Main, Germany. Phone: 49-69-6301-83647; Fax: 49-69-6301-5577. E-mail: ivan.dikic{at}biochem2.de

Abstract

Ubiquitin is an important regulator of diverse biological functions including cell cycle progression, apoptosis, cell proliferation, and DNA damage responses. Crucial proteins involved in the control of such diverse functions are modified by ubiquitin and are frequently altered during oncogenesis. Here, we define such proteins as key-nodes regulated by ubiquitin, discuss examples of their oncogenic aberrations, and indicate how pharmacologic manipulation of such molecular hubs might improve anticancer therapy. (Mol Cancer Res 2006;4(12):899–904)




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
T. D. Prickett, J. Ninomiya-Tsuji, P. Broglie, T. L. Muratore-Schroeder, J. Shabanowitz, D. F. Hunt, and D. L. Brautigan
TAB4 Stimulates TAK1-TAB1 Phosphorylation and Binds Polyubiquitin to Direct Signaling to NF-{kappa}B
J. Biol. Chem., July 11, 2008; 283(28): 19245 - 19254.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2006 by the American Association for Cancer Research.